This ab amount is > 10-fold lower than previously reported concentrations (10–20 μg/mL) used for staining tumor cell-PD-15 and also than clinical PD-1 ab serum titers (> 10–100 μg/mL) achieved in patients at time of administration48–50. Here, PDCD1 is linked to neoplasm.